Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001570523-18-000020)

Filing Details

Accession Number:: 0001570523-18-000020
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2018-03-30 17:03:59
Reporting Period:: 2017-12-31

Accepted Time:: 2018-03-30 17:03:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1559356	Immune Therapeutics Inc.	IMUN	Pharmaceutical Preparations (2834)	593226705

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1570523	Jackman Robert Dailey	401 First Street Los Altos CA 94022		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-28	1,000	$0.06	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-11-29	1,000	$0.16	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-11-29	1,000	$0.16	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-11-29	1,000	$0.06	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-11-29	1,000	$0.06	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-11-29	1,000	$0.06	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-11-29	1,000	$0.06	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-12-02	1,000	$0.06	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-12-06	1,000	$0.06	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-12-08	500	$0.07	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-12-14	1,250	$0.07	20,800,359	No	5	P	Direct
Common Stock	Acquisiton	2016-12-14	1,550	$0.07	20,800,359	No	5	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct
No	5	P	Direct